Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,821 | -29,306 | -18,547 | -9,170 | -28,079 |
| Depreciation Amortization | 266 | 184 | 114 | 59 | 252 |
| Accounts payable and accrued liabilities | 1,421 | -400 | 290 | 843 | -72 |
| Other Working Capital | 782 | -1,235 | -1,730 | -1,387 | 1,256 |
| Other Operating Activity | 4,163 | 4,614 | 2,523 | 581 | 4,890 |
| Operating Cash Flow | $-32,189 | $-26,142 | $-17,349 | $-9,074 | $-21,753 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -687 | -339 | -195 | -77 | -1,305 |
| Investing Cash Flow | $-687 | $-339 | $-195 | $-77 | $-1,305 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,022 | 11,022 | N/A | N/A | 3,000 |
| Debt Repayment | -1,489 | -1,489 | -1,107 | -547 | -534 |
| Common Stock Issued | 315 | 307 | 29 | 1 | 86,060 |
| Other Financing Activity | -764 | -764 | -545 | -549 | 50,992 |
| Financing Cash Flow | $9,085 | $9,077 | $-1,623 | $-1,096 | $139,518 |
| Beginning Cash Position | 130,189 | 130,189 | 130,189 | 130,189 | 13,729 |
| End Cash Position | 106,399 | 112,785 | 111,022 | 119,942 | 130,189 |
| Net Cash Flow | $-23,791 | $-17,405 | $-19,167 | $-10,247 | $116,460 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,189 | -26,142 | -17,349 | -9,074 | -21,753 |
| Capital Expenditure | -687 | -339 | -195 | -77 | -1,305 |
| Free Cash Flow | -32,875 | -26,482 | -17,545 | -9,151 | -23,058 |